oncology

3 articles

Experimental drug daraxonrasib doubles survival time in advanced pancreatic cancer trial

Experimental drug daraxonrasib doubles survival time in advanced pancreatic cancer trial

New daily pill doubles survival rates for pancreatic cancer patients

New daily pill doubles survival rates for pancreatic cancer patients

Mayo Clinic Researchers Find AI Can Detect Pancreatic Cancer Years Early

Mayo Clinic Researchers Find AI Can Detect Pancreatic Cancer Years Early